Redeye has a favorable view of SSH’s Q2 report – dominated by product development, operational milestones, and the consolidation of Deltagon. We anticipated a somewhat better top line, falling short of expectations. On a positive note, the company’s EBITDA was in the black. We expect to see a strong H2’21, and our fair value base case remains unchanged.